Company Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.

Equities

1349

CNE1000000W4

Pharmaceuticals

Market Closed - Hong Kong S.E. 04:08:16 2024-04-24 am EDT 5-day change 1st Jan Change
2.12 HKD +0.47% Intraday chart for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. +3.41% -16.86%

Business Summary

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd is a China-based company mainly engaged in research and development, manufacturing and marketing of biomedicine. The Company's products include aminolevulinic acid hydrochloride topical powder (trade name: ALA) and hemporfin or injection (trade name: FuMeiDa), and doxorubicin hydrochloride liposome injection (trade name: LIBOd), among others. Its products are mainly used for skin venereal disease treatment and anti-tumor treatment. The Company conducts its businesses in the domestic market.

Number of employees: 948

Sales per Business

HKD in Million2022Weight2023Weight Delta
Pharmaceutical Products
100.0 %
1,199 100.0 % 940 100.0 % -21.60%

Sales per region

HKD in Million2022Weight2023Weight Delta
China
100.0 %
1,199 100.0 % 940 100.0 % -21.60%

Managers

Managers TitleAgeSince
Founder 55 96-11-10
Founder 54 96-11-10
Director of Finance/CFO 43 10-05-31
Director/Board Member 51 01-10-31
Comptroller/Controller/Auditor - -

Members of the board

Members of the board TitleAgeSince
Director/Board Member 68 13-05-29
Director/Board Member 51 12-06-28
Director/Board Member 67 16-05-12
Founder 54 96-11-10
Director of Finance/CFO 43 10-05-31
Director/Board Member 55 23-05-29
Director/Board Member 51 01-10-31
Chairman 54 17-06-08
Director/Board Member 64 23-04-30
Director/Board Member - -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 710,572,100 215,912,309 ( 30.39 %) 0 45.47 %
Stock B 1 326,000,000 255,386,000 ( 78.34 %) 0

Shareholders

NameEquities%Valuation
70,564,000 21.65 % 19 M $
Invesco Hong Kong Ltd.
5.982 %
19,502,000 5.982 % 5 M $
Ashmore Equities Investment Management (US) LLC
0.1515 %
494,000 0.1515 % 135 707 $
Yan Xue
0.0153 %
50,000 0.0153 % 13 736 $
DFA Australia Ltd.
0.004740 %
15,454 0.004740 % 4 245 $
Capital International, Inc. (Investment Management Singapore)
0.000460 %
1,499 0.000460 % 412 $
NameEquities%Valuation
China New Enterprise Investment Co., Ltd.
22.08 %
156,892,912 22.08 % 161 M $
139,578,560 19.64 % 143 M $
80,000,000 11.26 % 82 M $
57,886,430 8.146 % 59 M $
Yong Su
2.629 %
18,677,860 2.629 % 19 M $
15,260,710 2.148 % 16 M $
Jun Li
1.269 %
9,018,200 1.269 % 9 M $
Shanghai Pudong Science & Technology Investment Co. Ltd.
0.9235 %
6,562,382 0.9235 % 7 M $
Yan Xue
0.2786 %
1,980,000 0.2786 % 2 M $
Guotai Asset Management Co., Ltd.
0.0123 %
87,113 0.0123 % 89 192 $

Company contact information

Shanghai Fudan Zhangjiang Bio Pharmaceutical Co., Ltd.

Zhangjiang Hi-Tech Park No. 308 Cailun Road

201210, Shanghai

+

http://www.fd-zj.com
address Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.(1349)
  1. Stock Market
  2. Equities
  3. 1349 Stock
  4. Company Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.